TOP STORY Magnetic Attraction of Stem Cells Creates More Potent Treatment for Heart Attack Researchers have found in animals that infusing cardiac-derived stem cells with micro-size particles of iron and then using a magnet to guide those stem cells to the area of the heart damaged in a heart attack boosts the heart’s retention of those cells and could increase the therapeutic benefit of stem cell therapy for heart disease. [Press release from EurekAlert! discussing online prepublication in Circulation Research]
|
|
SCIENCE NEWS Supplement Your Stem Cells Recent research suggests that a commercially-available supplement can increase the blood circulation of hematopoietic stem cells, which can give rise to all blood cells, and endothelial progenitor cells. [Press release from EurekAlert! discussing online prepublication in Journal of Translational Medicine] Scientists Grow Replacement Blood Vessels from Stem Cells Blood vessels engineered from laboratory-grown stem cells have worked well in animals, researchers say, and might someday replace the synthetic products now in use. [HealthDay Press Release]
|
|
CURRENT PUBLICATIONS Long-Term Outcome and Late Effects in Patients Transplanted with Mobilized Blood or Bone Marrow: A Randomized Trial More than nine years after transplantation, overall and leukemia-free survival remains similar in patients who underwent bone-marrow transplantation and peripheral blood progenitor cell transplantation. [Lancet Oncol] Magnetic Targeting Enhances Engraftment and Functional Benefit of Iron-Labeled Cardiosphere-Derived Cells in Myocardial Infarction Investigators sought to counter the efflux of transplanted cells by rendering them magnetically responsive and imposing an external magnetic field on the heart during and immediately after injection. [Circ Res] Genetic Modification of Mesenchymal Stem Cells Overexpressing CCR1 Increases Cell Viability, Migration, Engraftment, and Capillary Density in the Injured Myocardium Results demonstrate the in vitro and in vivo salutary effects of genetic modification of stem cells. Specifically, overexpression of chemokine receptor enhances the migration, survival and engraftment of mesenchymal stem cells, and may provide a new therapeutic strategy for the injured myocardium. [Circ Res] Generation of Induced Pluripotent Stem Cells from Human Adipose-Derived Stem Cells Without c-MYC Results show that human induced pluripotent stem cells can be generated by the transduction of three factors (OCT3/4, SOX2, and KLF4) into human adipose-derived stem cells. [Tissue Eng Part A] Survival and Immunogenicity of Mesenchymal Stem Cells From the Green Fluorescent Protein Transgenic Rat in the Adult Rat Brain Data indicate the usefulness of green fluorescent protein for investigating the survival of mesenchymal stem cells following transplantation to the brain. [Neurorehabil Neural Repair] Angiogenic Effects Despite Limited Cell Survival of Bone Marrow-Derived Mesenchymal Stem Cells Under Ischemia This study suggests that mesenchymal stem cell transplantation may be an effective and clinically relevant tool in the therapy of occlusive arterial diseases. [Thorac Cardiovasc Surg] Comparison of Proliferative and Multilineage Differentiation Potentials of Cord Matrix, Cord Blood, and Bone Marrow Mesenchymal Stem Cells Umbilical cord matrix mesenchymal stem cells are a dependable source of an unlimited number of mesenchymal stem cells for autologous and allogenic use in regenerative medicine. [Asian J Transfus Sci]
|
|
POLICY NEWS University of Chicago Physician Named to Presidential Commission for the Study of Bioethical Issues Daniel Sulmasy, MD, PhD, the Kilbride-Clinton Professor of Medicine and Ethics in the Department of Medicine and the Divinity School, and Associate Director of the MacLean Center for Clinical Medical Ethics at the University of Chicago, has been named to the Presidential Commission for the Study of Bioethical Issues. [Presidential Commission for the Study of Bioethical Issues, United States] National Human Genome Research Institute Names New Chief of Genome Technology Branch The National Human Genome Research Institute (NHGRI), part of the National Institutes of Health, has named Lawrence C. Brody, Ph.D., as the new chief of its Genome Technology Branch, the largest of seven branches in the NHGRI Division of Intramural Research. [National Institutes of Health, United States] Minor Use Minor Species Development of Drugs; Research Project Grant (R01) (RFA-FD-10-001) [National Institutes of Health, United States] Bioengineering Nanotechnology Initiative [STTR (R41/R42)] (PA-10-149) [National Institutes of Health, United States] Bioengineering Nanotechnology Initiative [SBIR (R43/R44)] (PA-10-150) [National Institutes of Health, United States] Clinical Investigator Status (Biologics) [Center for Biologics Evaluation and Research, United States] Background on Study Results of U.S. Academic Researchers [Center for Biologics Evaluation and Research, United States] May 7, 2010: Vaccines and Related Biological Products Advisory Committee Meeting Announcement [Center for Biologics Evaluation and Research, United States] Vaccines and Related Biological Products Advisory Committee; Notice of Meeting [Docket No. FDA-2010-N-0001] [Food and Drug Administration, United States] Secretary Sebelius Announces Five New Health and Human Services Regional Directors [Food and Drug Administration, United States]
|
|
EVENTS World Stem Cells & Regenerative Medicine Congress 2010 May 11-13, 2010 London, United Kingdom 16th Annual International Society for Cellular Therapy (ISCT) Meeting May 23-26, 2010 Philadelphia, United States Tissue Engineering & Regenerative Medicine International Society (TERMIS) – European Union 2010 June 13-17, 2010 Galway, Ireland International Society for Stem Cell Research (ISSCR) 8th Annual Meeting June 16-19, 2010 San Francisco, United States 5th World Congress on Preventative and Regenerative Medicine (WCRM) 2010 October 5-7, 2010 Hannover, Germany 2010 American Society for Matrix Biology (ASMB) Meeting October 24-27, 2010 Charleston, United States 52nd American Society of Hematology (ASH) Annual Meeting and Exposition December 4-7, 2010 Orlando, United States Tissue Engineering & Regenerative Medicine International Society (TERMIS) – North America 2010 Annual Conference December 5-8, 2010 Orlando, United States Visit our events page to stay up to date with the latest events in the cell, gene and immunotherapy community.
JOB OPPORTUNITIES
Reach more than 11,000 potential candidates by posting your organization’s career opportunities with Mesenchymal Cell News. Visit here to post your career opportunities.
Have we missed an important article or publication in Mesenchymal Cell News? Click here to submit!
|
| |
|